⏱ News is delayed by 15 minutes. Sign in for real-time access.
Sign in
PHAR News
Pharming Group N.V. ADS, each representing 10 ordinary shares
In Vivo Toxicology Market to Surpass USD 25.90 Billion by 2035; Rising Demand for Drug Safety Assessment and Expanding Biologics Pipeline Driving Market Growth – SNS Insider
globenewswire.com
PHAR
Pharming Group reports fourth quarter and full year 2025 financial results, delivering strong revenue growth and profitability with positive cash flow
globenewswire.com
PHAR
PHARM
INVESTOR ALERT: Pomerantz Law Firm Investigates Claims On Behalf of Investors of Pharming Group N.V. - PHAR
globenewswire.com
PHAR
INVESTOR ALERT: Pomerantz Law Firm Investigates Claims On Behalf of Investors of Pharming Group N.V. - PHAR
accessnewswire.com
PHAR
INVESTOR ALERT: Pomerantz Law Firm Investigates Claims On Behalf of Investors of Pharming Group N.V. - PHAR
accessnewswire.com
PHAR
INVESTOR ALERT: Pomerantz Law Firm Investigates Claims On Behalf of Investors of Pharming Group N.V. - PHAR
accessnewswire.com
PHAR
INVESTOR ALERT: Pomerantz Law Firm Investigates Claims On Behalf of Investors of Pharming Group N.V. - PHAR
accessnewswire.com
PHAR
INVESTOR ALERT: Pomerantz Law Firm Investigates Claims On Behalf of Investors of Pharming Group N.V. - PHAR
prnewswire.com
PHAR
Pharming Group to report fourth quarter and full year 2025 financial results and provide business update on March 12
globenewswire.com
PHAR
PHARM
INVESTOR ALERT: Pomerantz Law Firm Investigates Claims On Behalf of Investors of Pharming Group N.V. - PHAR
accessnewswire.com
PHAR